Page 17 - Lxrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hudson Capital Management LLC bought a new stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 15,038 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Other hedge funds and other institutional […]

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) CEO Lonnel Coats bought 10,000 shares of the company’s stock in a transaction that occurred on Monday, June 26th. The stock was bought at an average price of $2.18 per share, for a total transaction of $21,800.00. Following the acquisition, the chief executive officer now directly owns 804,359 […]

StockNews.com upgraded shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) to a sell rating in a report released on Tuesday. Several other research analysts have also recently issued reports on the company. Jefferies Financial Group began coverage on Lexicon Pharmaceuticals in a research report on Tuesday, March 7th. They issued a hold rating and a […]

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) CEO Lonnel Coats acquired 40,000 shares of the company’s stock in a transaction on Thursday, June 22nd. The shares were bought at an average price of $2.31 per share, for a total transaction of $92,400.00. Following the completion of the purchase, the chief executive officer now owns 784,359 […]

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) CEO Lonnel Coats bought 40,000 shares of Lexicon Pharmaceuticals stock in a transaction on Thursday, June 22nd. The stock was acquired at an average price of $2.31 per share, for a total transaction of $92,400.00. Following the purchase, the chief executive officer now owns 784,359 shares of the […]